Most Innovative AI Platform for Biologics – France 2025
PEACCEL IS LEADING THE WAY IN QUANTUM DRUG DISCOVERY. PEACCEL, winner of Global Tech Insider’s “Most Innovative AI Platform for Biologics – France 2025,” builds an AI- and Quantum-enhanced engine to accelerate biologics discovery. As pharma shifts from traditional screening to data-efficient design, PEACCEL sits at the intersection of two waves: advanced AI and practical Quantum learning. Our platform prioritizes high-quality biologic candidates earlier by learning from sparse, noisy experimental data, modeling epistasis, and reducing wet-lab cycles. The outcome is faster iteration, fewer experiments per program, and improved hit quality, translating technical performance into tangible R&D economics. PEACCEL supports both strategic partnerships and program co-development: rapid, metric-driven pilots that scale into full collaborations or licensing. With a strong, defensible IP position and validated results, we are expanding deployments with pharma teams and engaging venture partners to scale the platform and advance selected biologic assets.
